BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11856501)

  • 1. [5'NCR Incipient establishment of HCV 5'NCR transgenic mice model].
    Wang X; Guo P; Guan W; Cheng Y; Wang S
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):37-9. PubMed ID: 11856501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The construction and evaluation of antisense RNA expression vector targeting at HCV 5'NCR].
    Wang XH; Wang SQ; Guan W; Mao BZ
    Sheng Wu Gong Cheng Xue Bao; 2001 Mar; 17(2):179-82. PubMed ID: 11411227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The inhibitory effects of hepatocyte targeting pH-sensitive liposome mediated phosphorothioate antisense oligonucleotide on gene expression controlled by HCV 5'NCR].
    Wang XH; Wang SQ; Wen SY; Guan W; Mao BZ
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):626-30. PubMed ID: 11910753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effects of phosphorothioate antisense oligonucleotides on gene expression controlled by HCV 5'NCR in nude mice xenograft].
    Wang X; Wang S; Guan W; Mao B
    Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):285-7. PubMed ID: 11676874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific regulatory inhibition of transfected HepG(2) with HCV 5'NCR by antisense phosphorothioate oligodeoxynucleotides].
    Wang S; Wang X; Guan W; Li M
    Zhonghua Gan Zang Bing Za Zhi; 2000 Oct; 8(5):288-90. PubMed ID: 11058954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.
    González-Carmona MA; Vogt A; Heinicke T; Quasdorff M; Hoffmann P; Yildiz Y; Schneider C; Serwe M; Bartenschlager R; Sauerbruch T; Caselmann WH
    J Hepatol; 2011 Jul; 55(1):19-28. PubMed ID: 21145870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction and identification of HBD-2 transgenic mice].
    Zhang S; Huang N; Zhao X; Wang Q; Yang Y; Cheng Y; Ju H; Xiong W; Chu G; Li X; Wang B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Apr; 23(2):396-9. PubMed ID: 16706375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of an expression vector with a bicistron of green fluorescent protein and HCV 5'NCR controlled luciferase gene and its expression in hepatocytes].
    Liu SP; Tan DM; Hou ZH
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):20-2. PubMed ID: 12934387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
    Kim M; Shin D; Kim SI; Park M
    Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term hepatitis C internal ribosome entry site-dependent gene expression mediated by phage phiC31 integrase in mouse model.
    Sun Z; Wang Y; Fu Q; Zhou Y; Jia S; Du J; Peng J; Wang Y; Yang S; Zhan L
    Antivir Ther; 2009; 14(3):393-400. PubMed ID: 19474473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and the significance of a cell model of secreted alkaline phosphatase co-controlled by HCV 5'NCR and NS3 serine protease].
    Liu SP; Tan DM; Yang YF; Hou ZH
    Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):552-3. PubMed ID: 15387910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The establishment of conditional MT transgenic mice model].
    Wang YA; Zheng JW; Fei ZL; Jiang XQ; Li JZ; Xu Q; Wang ZG; Fei J; Zhang ZY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):260-4. PubMed ID: 16767659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment of a tight tetracycline-controlled HCV-C double transgenic mouse model].
    Shuai LF; Tang BH; Zhang RS; Zhao Y; Yang GZ; Cheng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1530-3. PubMed ID: 18819860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pronuclear injection for the production of transgenic mice.
    Ittner LM; Götz J
    Nat Protoc; 2007; 2(5):1206-15. PubMed ID: 17546016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of transgenic mice for cardiovascular research.
    Tian XL; Wang QK
    Methods Mol Med; 2006; 129():69-81. PubMed ID: 17085805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of inducible hepatitis C virus transgenic mouse lines.
    Ernst E; Schönig K; Bugert JJ; Bläker H; Pfaff E; Stremmel W; Encke J
    J Med Virol; 2007 Aug; 79(8):1103-12. PubMed ID: 17596832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
    Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
    J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Core protein of hepatitis C virus expressed in transgenic mice is associated with the expression of Fas molecule].
    Tan W; Lang Z; Cong Y; Chen G; Miao J; Zhan M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):205-7. PubMed ID: 15617329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the 3'noncoding region of Chinese hepatitis C virus genome].
    Lan S; Yuan Z; Hu Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):153-6. PubMed ID: 12569785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.
    Smith DB; Mellor J; Jarvis LM; Davidson F; Kolberg J; Urdea M; Yap PL; Simmonds P
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1749-61. PubMed ID: 9049380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.